PHIO (Phio Pharmaceuticals) Wutah bathi ing taun lumaku
Phio Pharmaceuticals relies on the efficiency of its RNA platform for eye and skin therapies. Current year-over-year EPS dynamics confirm this trajectory, with the parameter reaching -1.30. Prospects are bolstered by robotic drug screening and the stable operation of laboratory capacities without downtime, creating a foundation for the company's further financial growth.
Rincian metrik keuangan lan pasar RXi Pharmaceuticals (PHIO)
- rega saham lan target rega konsensus:
- indikator valuasi pasar bisnis:
- data kapitalisasi buku:
- rincian utang lan likuiditas:
Total Utang marang Modal Phio Pharmaceuticals|PHIO - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Phio Pharmaceuticals Corp|PHIO - Gunggung utang perusahaan|Utang-utang marang nilai buku Phio Pharmaceuticals Corp|PHIO - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Phio Pharmaceuticals|Rasio likuiditas perantara phiopharma.com
- indikator pendapatan resik lan kelipatan nilai:
PHIO - Bathi resik|Prakiraan bathi perusahaan Phio Pharmaceuticals|PHIO - Pangali P/E|Prakiraan rega marang bathi Phio Pharmaceuticals Corp|PHIO - Pangali PEG|Pangali EV/EBITDA Phio Pharmaceuticals Corp.|PHIO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Phio Pharmaceuticals|PHIO - Bathi saben saham sajrone rolas wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan phiopharma.com|PHIO - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep Phio Pharmaceuticals
- data pendapatan lan penerimaan dodolan:
Pambiji fundamental:PHIO Phio Pharmaceuticals Corp.
For Phio Pharmaceuticals (PHIO), which utilizes the scalable INTASYL platform to develop RNA therapies, the annual percentage growth of net income per share reflects the efficiency of its manufacturing outsourcing model. This metric measures EPS dynamics by comparing current financial results with the same period last year. A positive trend confirms the ability of the intellectual property to generate super-margins without capital expenditures. It is critical for investors to assess the stability of the curve relative to the sector, as sharp fluctuations in the indicator signal the current phase of the company's technological cycle.
Pesaing wigati
Tempus AI, Inc (TEM) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun lumaku Qiagen|IONS: Tambahing bathi saben saham ing taun lumaku|Wutah bathi resik saben saham ing taun iki RGEN (Repligen)|Prakiraan wutah bathi resik saben saham ing taun iki Avidity Biosciences Inc|Wutah bathi ing taun lumaku CRSP (crisprtx.com)|WGS: Wutah bathi saben saham ing taun iki|RARE: Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham ing taun lumaku BEAM|Sarepta (SRPT) - Wutah bathi saben saham ing taun lumaku|TWST - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku 10x Genomics, Inc.|NTLA: Tambahing bathi saben saham ing taun lumaku|Wutah bathi resik saben saham ing taun iki STOK (Stoke Corp)|Prakiraan wutah bathi resik saben saham ing taun iki biolifesolutions.com|Wutah bathi ing taun lumaku WVE (Wave Life Sciences Ltd)|Prakiraan wutah bathi resik saben saham ing taun iki Maze Therapeutics (MAZE)|SION: Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham ing taun iki Prime Medicine Bio PRME|TSHA: Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun iki QURE|Wutah bathi resik saben saham ing taun iki MGTX|Wutah bathi saben saham ing taun iki RGNX (REGENXBIO)|Wutah bathi ing taun lumaku SLDB|OCGN - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Pacific Biosciences of California PACB|BNTC: Wutah bathi saben saham ing taun iki|DSGN - Wutah bathi saben saham ing taun lumaku|RCKT: Wutah bathi saben saham ing taun lumaku|FDMT - Wutah bathi resik saben siji saham kanggo taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Lexeo Therapeutics Inc. (LXEO)|Wutah bathi saben saham ing taun lumaku Korro Bio Inc.|Editas Medicine (EDIT) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku Silence Therapeutics Inc. (SLN)|PRQR: Dinamika bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku CDXS (codexis.com)|SGMO: Wutah bathi saben saham ing taun iki|NAUT: Wutah bathi resik saben saham ing taun iki|Kacepetan wutah bathi saben saham ing taun lumaku metagenomi.co|Precision BioSciences, Inc. (DTIL) - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Generation Bio Corp (GBIO)|Wutah bathi resik saben saham ing taun iki BOLD|exicuretx.com (XCUR) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben saham ing taun iki IMNN (Celsion Corporation)|Mustang Bio - Wutah bathi saben saham ing taun iki|TransCode Therapeutics, Inc. - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham ing taun iki Bionano Genomics, Inc. (BNGO)|APDN - Wutah bathi saben saham ing taun lumaku|Tambahing bathi saben saham ing taun lumaku BLUE (Bluebird Bio)|ImmunoPrecise (IPA) - Wutah bathi saben saham ing taun lumaku|OMGA: Wutah bathi resik saben siji saham kanggo taun lumaku|Wutah bathi saben saham ing taun lumaku Singular Genomics Systems, Inc.|Wutah bathi ing taun lumaku Regulus Therapeutics, Inc.|Wutah bathi resik saben saham ing taun iki SYRS (Syros)|TBIO - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku TRACON Pharmaceuticals, Inc. TCON|Unity Biotechnology (UBX) - Kacepetan wutah bathi saben saham ing taun lumaku
